A comparison of the antifibrillatory effects of desethylamiodarone to amiodarone in a swine model

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 3, 1999, Pages 440-445

  Zhou, Li ^a   White, C Michael ^a,b,c   Chen, Bonnie P ^a   Chow, Moses S S ^d   Fan, Chengde ^a   Kluger, Jeffrey ^a,b,c  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Amiodarone; Antiarrhythmic; Antifibrillatory; Correlation; Desethylamiodarone; VFT

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEETHYLAMIODARONE; ENCAINIDE; LIDOCAINE; SODIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAM; HEART VENTRICLE FIBRILLATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; INJECTIONS, INTRAVENOUS; SWINE; VENTRICULAR FIBRILLATION;

EID: 0032864513     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199909000-00019     Document Type: Article

References (24)

1. Chow MSS. Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use. Ann Pharmacother 1996;30:637-43.
2. Lu HR, Remeysen P, De Clerk F. Antifibrillatory action of class I-IV antiarrhythmic agents in the model of ventricular fibrillation threshold of anesthetized guinea pigs. J Cardiovasc Pharmacol 1995;26:132-6.
3. Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989;13:1353.
4. Akhtar M, Jazayeri M, Sra J, et al. Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation. PACE Pacing Clin Electrophysiol 1993;16:511.
5. Wever EFD, Hauer RNW, Crijns HJGM, et al. Dutch prospective randomized trial of implantable defibrillator as first-choice therapy in post-infarct sudden death survivors versus conventional strategy [Abstract]. Eur J Cardiol 1994;15:344.
6. Chow MSS, Kluger J, Dipersio D, et al. Antifibrillatory effects of lidocaine and bretylium immediately post-cardiopulmonary resuscitation. Am Heart J 1985;110:938-43.
7. Hanyok JJ, Chow MSS, Kluger J, et al. Antifibrillatory effect of high dose bretylium and lidocaine-bretylium combination during cardiopulmonary resuscitation. Crit Care Med 1988;16:691-4.
8. Cummins RO, ed. Textbook of advanced cardiac life support. American Heart Association, Dallas, TX, 1994.
9. Caims JA, Connolly SJ, Roberts R, et al., for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet 1997;349:675-82.
10. Jullian DG, Camm AJ, Frangin G, et al., for the European Myocardial Infarct Amiodarone Trial Investigators. Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-74.
11. Medical Education Network (MEDI-FAX). Antiarrhythmic therapy significantly increases survival to hospital in patients with shock-refractory cardiac arrest. Presented at the American Heart Association's 70th Scientific Sessions, Orlando, Florida; November 9-12, 1997.
12. Morady F, DiCarlo LA, Krol R, Baerman JM, DeBuitleir M. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction. J Am Coll Cardiol 1986;7:148-57.
13. Patterson E, Eller BT, Abrams GD, Vasiliades J, Lucchesi BR. Ventricular fibrillation in a conscious canine preparation of sudden coronary death: prevention by short and long-term amiodarone administration. Circulation 1983;68:857-64.
14. Ohta M, Karagueuzian HS, Mandel WJ, Peter T. Acute and chronic effects of amiodarone on delayed afterdepolarization and triggered automaticity in rabbit ventricular myocardium. Am Heart J 1987; 113:289-96.
15. Zhou L, Chen BP, Kluger J, Fan A, Chow MS. Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold. J Am Coll Cardiol 1998;31: 1672-8.
16. Arredondo MT, Guillen SG, Quinteiro RA. Effect of amiodarone on ventricular fibrillation and defibrillation thresholds in the canine heart under normal and ischemic conditions. Eur J Pharmacol 1986;125:23-28.
17. Lubbe WF, McFayden ML, Muller CA, Wothington M, Opie LH. Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart. Am J Cardiol 1979;43:533-40.
18. Holhnloser SH, Meinertz T, Dammbacher T, et al. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo controlled study. Am Heart J 1991; 121:89-95.
19. 3, and the QT interval during long-term amiodarone treatment. Am Heart J 1986;111:644-8.
20. Anderson JL, Rodier HE, Green LS. Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am J Cardiol 1983;51:1196-202.
21. Tisdale JE, Sun H, Zhao H, et al. Antifibrillatory effect of esmolol alone and in combination with lidocaine. J Cardiovasc Pharmacol 1996;27:376-82.
22. Lu HR, Remeysen P, De Clerck F. Antifibrillatory action of class I-IV antiarrhythmic agents in the model of ventricular fibrillation threshold of anesthetized guinea pigs. J Cardiovasc Pharmacol 1995;26:132-6.
23. Bui-Xuan B, Aupetit JF, Freysz M, Faucon G, Timour Q. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ. Pharmacotherapy 1997;17:737-45.
24. Liu P, Fei L, Wu W, Li J, Wang J, Zhang X. Effects of hypothyroidism on the vulnerability to ventricular fibrillation in dogs: a comparative study with amiodarone. Cardiovasc Drugs Ther 1996; 103:369-78.